Securities code: Xiamen Amoytop Biotech Co.Ltd(688278) securities abbreviation: Xiamen Amoytop Biotech Co.Ltd(688278) Announcement No.: 2022016 Xiamen Amoytop Biotech Co.Ltd(688278)
Announcement on using some idle self owned funds for cash management
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Xiamen Amoytop Biotech Co.Ltd(688278) (hereinafter referred to as "the company") held the sixth meeting of the eighth board of directors and the third meeting of the eighth board of supervisors respectively on March 30, 2022. The proposal on using part of idle self owned funds for cash management was reviewed and approved by unanimous vote, and it was agreed that the company should use no more than 300 million yuan (including this amount) of idle self owned funds for cash management, The authorization period is 12 months from the date of deliberation and approval by the board of directors, and the above amount can be recycled and used within the period. This matter does not need to be submitted to the general meeting of shareholders for deliberation. The relevant information is hereby announced as follows:
1、 Basic information of cash management
(I) purpose of cash management
On the premise of ensuring that the company's daily operation capital demand and capital safety are not affected, appropriate cash management of idle self owned funds is conducive to improving the efficiency of capital use, increasing investment income and obtaining more returns for the company and shareholders.
(II) source of funds
The company's own funds temporarily idle.
(III) cash management limit and term
The total investment amount shall not exceed 300 million yuan (including this amount), and the investment period shall be 12 months from the date of deliberation and approval by the board of directors. Within the above-mentioned period and amount, the funds can be used on a rolling basis.
(IV) scope of cash management investment
It mainly invests in financial products with low risk, high liquidity and investment period of no more than 12 months, including but not limited to financial products with low risk issued by banks, securities companies and other financial institutions.
(V) implementation mode
Within the investment limit, the management of the company is authorized to study and decide the above specific matters of cash management and report to the general manager for approval.
(VI) information disclosure
The company will timely fulfill the obligation of information disclosure in accordance with the requirements of relevant laws, regulations and normative documents, such as the company law, the securities law, the Listing Rules of science and Innovation Board of Shanghai Stock Exchange and so on.
2、 Investment risk and risk control measures
The company will carefully choose financial products with high safety and good liquidity, but it still does not rule out the situation that affects the income due to market fluctuations, changes in macro financial policies and other reasons. For possible investment risks, the company will take the following risk control measures:
1. The company will establish and improve the approval and implementation procedures of cash management in accordance with the principle of separating decision-making, implementation and supervision functions, so as to ensure the effective development and standardized operation of cash management and ensure the safety of funds.
2. The financial center of the company will establish a fund use account, register and manage cash management products, and timely analyze and track investment progress and income. If the assessment finds that there are risk factors that may affect the safety of the company's funds, corresponding measures will be taken in time to control the investment risk.
3. The Audit Department of the company is responsible for auditing and supervising the cash management.
4. The independent directors and the board of supervisors of the company have the right to supervise and inspect the use of the above idle self owned funds, and can hire professional institutions to audit when necessary.
5. The company will perform the obligation of information disclosure in accordance with relevant laws and regulations.
3、 Impact on the company's operation
The use of some idle self owned funds for cash management is carried out on the premise of ensuring the capital demand of the company's daily operation and effectively controlling investment risks, which will not affect the normal development of the company's main business and do not damage the interests of the company and shareholders. Through the appropriate management of idle self owned funds, we can improve the use efficiency of funds, obtain certain investment benefits, and obtain more investment returns for the company and shareholders.
4、 Review procedure
On March 30, 2022, the company held the sixth meeting of the eighth board of directors and the third meeting of the eighth board of supervisors respectively. The proposal on the use of some idle self owned funds for cash management was deliberated and approved by a unanimous vote. It was agreed that the company would use the total amount of no more than 300 million yuan (including this amount) to temporarily idle its own funds for cash management, and the authorization period was 12 months from the date of deliberation and approval by the board of directors, The above quota can be recycled and rolled within the term. The independent directors of the company expressed their independent opinions on this matter.
5、 Description of special opinions
(I) opinions of independent directors
The independent directors of the company believe that under the premise of complying with national laws and regulations, ensuring the safety of investment funds and not affecting the normal operation of the company, the company uses some idle self owned funds for cash management, which is conducive to improving the efficiency of fund use and obtaining investment income, and there is no situation that damages the interests of the company and shareholders (especially minority shareholders). It is agreed that the company will use idle self owned funds of no more than RMB 300 million (including this amount) for cash management.
(II) opinions of the board of supervisors
The board of supervisors believes that through appropriate cash management of idle self owned funds, we can obtain certain investment income and better investment return for the company and shareholders. Combined with the actual use of the company's own funds, it is agreed that the company will use the total amount of no more than 300 million yuan (including this amount) to temporarily idle its own funds for cash management for a period of 12 months. Within the above-mentioned period and amount, the funds can be used on a rolling basis.
It is hereby announced.
Xiamen Amoytop Biotech Co.Ltd(688278) board of directors
March 31, 2022
